MA in Journalism from the University of Sunderland, NCTJ accreditation,
Experience
Editor of Cannabis Health (2019-2023); Contributor at Forbes (2023-present); Panel Moderator at Cannabis Europa, Product Earth, and Drug Science’s UK Patient Conference (2023); Reporter on women’s health, health technology, biotech, longevity, and neurorehabilitation medicine.
Written For
Forbes, Cannabis Health, Business of Cannabis, Drug Science.
Sarah is a highly respected journalist, with over a decade of experience in publishing and communications, the last four of which have been in specialist healthcare sectors.
She is one of the few UK journalists specialising in cannabis-related health and policy, with work that spans the fields of science, medicine, wellness and drug policy. As the former editor of Cannabis Health, an industry-leading and award-winning title covering the potential of cannabis for health and wellbeing, she has been at the forefront of the UK medical cannabis sector for the last four years and has reported extensively, with a particular focus on patients and consumers. Under Sarah’s leadership, Cannabis Health won 'Best CBD Magazine' at the World CBD Awards 2022.
She is now a regular contributor to Forbes, covering cannabis with a focus on Europe and has moderated panels at leading industry events, including Cannabis Europa, Product Earth and Drug Science’s UK Patient Conference, which she helped curate in November 2023.
Beyond cannabis, Sarah also has experience reporting on women’s health, health technology, biotech, longevity and neurorehabilitation medicine. She has an NCTJ accreditation and graduated from her MA in Journalism at the University of Sunderland with a distinction. She has also completed specialist training through the Medical Cannabis Clinicians Society in the UK.
Sarah is passionate about tackling stigma and misinformation with science, without losing sight of the importance of the patient experience. Through her journalism and content, she helps readers navigate complex topics in a way that resonates and aims to empower individuals to make informed decisions about their health and wellbeing, with accurate, evidence-based information.
Starting your journey with medical cannabis treatment can be daunting, especially if it’s not something you’ve tried before. Many people are hesitant, not because they doubt the efficacy of the medication, but because of the social stigma which can come with it.
Yesterday (Sunday 6th October) marked World Cerebral Palsy Day, a global movement which aims to raise awareness, and ensure a future in which those with Cerebral Palsy have the same rights and opportunities as everyone else.
CBG (cannabigerol) is a naturally occurring cannabinoid found in the cannabis plant with promising potential for therapeutic use. Since its discovery in 1964, CBG has been the focus of many laboratory and animal studies. Although human clinical trials remain relatively limited, early research suggests CBG has significant potential across a range of health conditions, from easing anxiety to tackling antimicrobial resistance. Unlike THC, CBG does not produce a psychoactive high.
A lot of the content around medical cannabis focuses on its therapeutic benefits (and rightly so) from pain relief to easing anxiety. But for many first-time users, a question that often comes up is: What does medical cannabis taste like?
World Suicide Prevention Day takes place every year to tackle stigma and raise awareness of this major global health issue and how it can be prevented.
Because they affect around one in seven people, Migraine Awareness Week is a crucial initiative to spotlight the significant impact migraines have on millions of lives worldwide. With conventional treatments not always able to provide adequate relief, medical cannabis has emerged as a promising alternative.
Fibromyalgia is a chronic condition which can be hard to diagnose and hard to treat. But in many patients— and supported by a growing evidence base— medical cannabis is showing promise for symptom management and improving quality of life. We take a closer look at the research and hear from those with first-hand experience.
Although medical cannabis has been legal in the UK for almost six years—and around 35,000 patients now hold prescriptions—there is still a lot of confusion around its legality and what you can and cannot do when using your medication in day to day life. Here we take a look at the things you may need to consider when it comes to consuming your medication in public.
As Keir Starmer becomes the new UK Prime Minister, what impact—if any—will a Labour government have on medical cannabis policy? On Friday, 5 July, the UK woke up to a new era as Keir Starmer was elected as the first Labour Prime Minister in 14 years.
Up to 40% of the population are thought to be affected by sciatica, which can cause a number of debilitating symptoms. But where other treatments have failed, medical cannabis may hold promise for reducing pain and improving patients’ overall wellbeing.
In the last two decades, global plastic production has doubled, with 400 million tonnes of plastic waste now produced every year. As one of the only UK clinics to provide medical cannabis flower in eco-friendly packaging, Releaf is committed to finding more sustainable solutions this Plastic Free July and is taking steps towards a plastic-free future.
The vast majority of patients experiencing chronic pain are women, yet one in two say they have had their pain “ignored” or “dismissed”. We take a close look at the gender pain gap.
CBD flower and medical cannabis cultivars are often conflated, but while they may look and smell similar, there are significant differences when it comes to their chemical composition, intended use, regulatory status, and effects. CBD flower is illegal in the UK, while medical cannabis flower can only be prescribed by a specialist doctor.
With those deployed in the Armed Forces at greater risk of experiencing mental health conditions such as PTSD, we explore the potential benefits of medical cannabis treatment among the veteran community.
Medical cannabis has been legal in the UK since 2018, but the prescription of cannabis-based products for medicinal use (CBPMs) is a strictly regulated and complicated process. Here we’ll take a closer look.
In our educational series, we’ve been exploring the effects of terpenes—beyond their aroma—to better understand their importance in medical cannabis treatment. Here we take a closer look at the potential of Alpha-Pinene.
In the latest in our educational series looking beyond the aroma to explore the therapeutic potential of terpenes, we examine humulene. As well as being associated with the distinct, hoppy smell of beer, humulene is one of the most abundant terpenes found in cannabis and has some interesting medicinal properties worthy of further exploration.
Have you ever read the list of side-effects for a newly-prescribed medication and wondered whether it’s really safe to consume? Rest-assured that the drug has been through a lengthy and strict approval process before making its way to your local pharmacy.
Longer days, lush green leaves—and a streaming nose; all sure-fire signs that spring is finally here in abundance. But is your medical cannabis prescription a help or a hindrance?
This year’s Mental Health Awareness Week, taking place from 13-19 May, 2024 is all about movement — and why it’s so important for our mental health. Can medical cannabis help get people moving more? We take a look.
Earth Day (22 April) is an annual celebration of our natural environment — and more important than ever amid the global climate crisis. How can those entering the emerging medical cannabis industry ensure they adopt eco-friendly practices from the off?
Many medical cannabis products in the UK have undergone a process known as irradiation, but what is the difference between these and non-irradiated products? Here’s everything you need to know.